1. Home
  2. BZUN vs AGEN Comparison

BZUN vs AGEN Comparison

Compare BZUN & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Baozun Inc.

BZUN

Baozun Inc.

HOLD

Current Price

$2.71

Market Cap

155.4M

ML Signal

HOLD

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$3.47

Market Cap

126.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BZUN
AGEN
Founded
2007
1994
Country
China
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
155.4M
126.2M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
BZUN
AGEN
Price
$2.71
$3.47
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$14.50
AVG Volume (30 Days)
202.8K
457.8K
Earning Date
11-25-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,372,022,139.00
$106,829,000.00
Revenue This Year
$5.92
$67.15
Revenue Next Year
$3.80
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.08
N/A
52 Week Low
$2.12
$1.38
52 Week High
$4.88
$7.34

Technical Indicators

Market Signals
Indicator
BZUN
AGEN
Relative Strength Index (RSI) 37.59 30.93
Support Level $2.58 $3.82
Resistance Level $2.76 $3.79
Average True Range (ATR) 0.12 0.25
MACD 0.00 -0.07
Stochastic Oscillator 26.04 33.83

Price Performance

Historical Comparison
BZUN
AGEN

About BZUN Baozun Inc.

Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including strategy and tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.

About AGEN Agenus Inc.

Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).

Share on Social Networks: